NEW YORK (GenomeWeb) – Roka Bioscience reported on Friday that its second quarter revenues rose 20 percent year over year thanks to an increase in the number of Atlas molecular pathogen detection instruments placed with customers.

For the three months ended June 30, the firm reported total revenues of $1.8 million, up from $1.5 million a year ago. As of June 30, the company had placed 46 instruments with customers under commercial agreements, up from 44 instruments as of March 31.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.